(2026). Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: Results of a pharmacokinetic study. Open Forum Infectious Diseases.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Once-daily Dolutegravir–based Antiretroviral Therapy Amongst Adults with Advanced HIV Disease Receiving 1-month of Daily Rifapentine and Isoniazid for TB Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study."
Open Forum Infectious Diseases 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Once-daily Dolutegravir–based Antiretroviral Therapy Amongst Adults with Advanced HIV Disease Receiving 1-month of Daily Rifapentine and Isoniazid for TB Preventive Therapy and Fluconazole for Treatment of Cryptococcal Meningitis: Results of a Pharmacokinetic Study."
Open Forum Infectious Diseases, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.